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Filoviruses, including Ebola virus, are cytotoxic. To investigate the role of the Ebola virus glycoprotein (GP) in this
cytopathic effect, we transiently expressed the GP in human kidney 293T cells. Expression of wild-type GP, but not the
secretory form of the molecule lacking a membrane anchor, induced rounding and detachment of the cells, as did a chimeric
GP containing its ectodomain and influenza virus hemagglutinin transmembrane–cytoplasmic domain. These results indicate
that the GP ectodomain and its anchorage to the membrane are required for GP-induced morphologic changes in host cells.
Since cell rounding and detachment could be associated with reduced levels of cell adhesion molecules, we also studied the
expression of integrins, which are major molecules for adhesion to extracellular matrices, and found that the b1 integrin
group is downregulated by the GP. This result was further extended by experiments in which anti-b1 monoclonal antibodies
or purified integrins inhibited the infectivity of vesicular stomatitis virus pseudotyped with the GP. We suggest that integrins,
especially the b1 group, might interact with the GP and perhaps be involved in Ebola virus entry into cells. © 2000 Academic
PressEbola virus, a filamentous, enveloped, negative-strand
RNA virus in the family Filoviridae, causes severe hem-
rrhagic fever in humans and other primates (11). Four
ubtypes of the virus have been identified: Zaire, Sudan,
vory Coast, and Reston (12). The fourth gene from the 39
nd of the Ebola virus nonsegmented genome encodes
wo glycoproteins: the primary product, termed nonstruc-
ural secretory glycoprotein (SGP), is secreted from in-
ected cells (11), while the envelope glycoprotein (GP) is
esponsible for virus binding to cell surface molecules
nd penetration. The GP is expressed by transcriptional
diting, resulting in the addition of an extra adenosine
ithin a run of seven adenosines in the coding region of
he molecule (12, 15).
Both GP and SGP are thought to be involved in the
athogenesis of Ebola virus infection. SGP is reported to
ind to neutrophils via the Fcg receptor and inhibit the
early activation of neutrophils (16). In contrast to SGP, GP
is thought to contribute to tissue tropism, since a murine
retroviral vector pseudotyped with Ebola GP infected
endothelial cells more efficiently than other cell types
tested (16). The destruction of endothelial cells by Ebola
viruses likely contributes to the hemorrhagic manifesta-
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20tions that characterize filovirus infections (13), although
the precise mechanism(s) of this effect remains un-
known. As an initial step in understanding the pathogen-
esis of filovirus infection, we investigated the cytopathic
effects produced by Ebola virus in cultured cells (11),
focusing on the pathogenic contributions of the GP and
SGP.
Transient expression of GP or SGP (Fig. 1A) in 293T
cells blocked the growth of transfected cells (data not
shown). Expression of the GP, but not the SGP, induced
morphologic rounding and detachment of the cells (Figs.
1B and 1C), suggesting the importance of membrane
anchorage of this molecule for cytopathic effects. This
prediction was tested with a mutant GP lacking the
transmembrane–cytoplasmic domain. Since the mutant
was designed to be secreted into the culture medium, it
was designated secreted GP (secGP; Fig. 1A). Cross-
linking analysis revealed that the secGP formed a trimer,
as does authentic GP (data not shown). However, ex-
pression of the secGP did not affect cell morphology
(Figs. 1B and 1C). These findings confirm a role of the
transmembrane and cytoplasmic domains in the cyto-
pathic effects of Ebola virus.
To determine which of the GP domains participates in
cytopathic effects, we substituted the transmembrane–
cytoplasmic domain of GP with that of influenza virus
hemagglutinin (HA) and vice versa (Fig. 1A). These chi-
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21RAPID COMMUNICATIONmeric mutants, the wild-type GP, and the influenza virus
HA were expressed in 293T cells and the resultant cy-
topathologic effects were assessed (Fig. 1B). Expression
of the mutant containing the Ebola GP transmembrane
and cytoplasmic tail region and the HA ectodomain
(ecHAtmEB) did not affect cell morphology. By contrast,
the chimera containing the GP ectodomain and the other
domains from the influenza HA (ecEBtmHA) induced cy-
topathic effects similar to those seen with wild-type GP
(although to a lesser extent). Thus, the GP ectodomain
may serve as a functional domain to induce morphologic
changes in host cells, with membrane anchorage of the
GP being a requirement for this effect.
Because of their role in cell adhesion to extracellular
matrices, including fibronectin, vitronectin, and collagen
(3), integrins might be involved in the cytopathic effects
caused by Ebola GP. These molecules constitute a su-
perfamily of heterodimers with noncovalently associated
a- and b-chain subunits, both of which are N-glycosy-
ated transmembrane proteins (3). We focused on the cell
urface expression of the b1 group, also known as VLA
receptors, since they exist ubiquitously in a wide variety
of cells (3). 293T cells were transfected with a plasmid
expressing the GP of the Zaire or Reston strain of Ebola
virus or the influenza virus HA and analyzed by FACS for
cell surface expression of integrins. We found that both
the Zaire and the Reston GPs downregulated the surface
expression of b1 integrins, as indicated by the reduced
xpression of these molecules in GP-expressing (phyco-
FIG. 1. (A) Schematic diagram of mutant GPs. The secGP contains on
(A/turkey/Ireland/1378/83; H5N8) HA (IfV HA) ectodomain (residues
GP644-676). The ecEBtmHA contains Zaire GP ectodomain (positions G
(B) Morphologic changes induced by the expression of Ebola and influe
virus HA, and chimeric protein (ecHAtmEB and ecEBtmHA) genes w
transfected into 293T cells. Pictures were taken 24 h posttransfectio
glycoproteins. 293T cells were transfected with a protein expression pl
immunologic detection of the proteins with polyclonal (Ebola glyco
percentages of cells are expressing the indicated protein.rythrin-positive) cells (Fig. 2A, panels 1 and 2). By con-
rast, the influenza virus HA did not affect cell surface fxpression of the b1 integrins on the cell surface (Fig.
A, panel 3). Similar results were obtained with the aV
ubunit (Fig. 2A, panels 5–7), but only minimal downregu-
ation was observed with the other a molecules tested
(a1 a2 a3, a4, a5, and a6; see results for a5 in Fig. 2A,
anels 9–12, for an example). Expression of the other b
molecules tested (b2 and b3) was below the detec-
tion level of our assay using 293T cells. The chimera
ecEBtmHA (i.e., GP ectodomain and HA transmembrane-
cytoplasmic domain), but not ecHAtmEB (HA ectodomain
and GP transmembrane-cytoplamic domain), also re-
duced the expression of b1 integrins (Fig. 2B), although
o a lesser extent than the wild-type GP. Thus, downregu-
ation of b1 integrins is likely to be associated with the
ytopathic effects caused by Ebola virus.
We speculate that Ebola virus GPs and integrin mole-
ules interact, leading to integrin downregulation on the
ell surface. This mechanism is reminiscent of the rela-
ionship between gp 160, a human immunodeficiency
irus glycoprotein, and its CD4 receptor (2, 4–6, 8, 9). The
p 160 reduces cell surface delivery of the CD4 molecule
y interacting with it to form gp160–CD4 complexes in
he endoplasmic reticulum that are thought to block the
ntracellular transport and delivery of CD4 to the plasma
embrane (5, 9). Nonanchored gp160 does not produce
his effect (8). Thus, these similarities suggest that the
ytopathologic effects observed in Ebola GP-expressing
ells might be caused by such “receptor interference.”
To examine the potential role of b1 integrins in Ebola
bola Zaire GP ectodomain. The ecHAtmEB contains the influenza virus
523) and Ebola GP transmembrane–cytoplasmic domain (residues
) and HA transmembrane–cytoplasmic domain (positions HA522–566).
s glycoproteins. Ebola Zaire and Reston GP and SGP, secGP, influenza
ned into a mammalian expression vector, pCAGGS/MCS (7, 10), and
mmunologic detection of cells expressing Ebola and influenza virus
as described for B), fixed 24 h posttransfection, and processed for the
s) or monoclonal (influenza virus HA) antibodies. Note that similarly the E
HA1–
P1–641
nza viru
ere clo
n. (C) I
asmid (
proteinvirus entry, we tested 10 anti-b1 monoclonal antibodies
or their ability to block the infectivity of vesicular stoma-
22 RAPID COMMUNICATIONFIG. 1—Continued
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24 RAPID COMMUNICATIONtitis virus (VSV) pseudotyped with Ebola GP. Two of the
antibodies (MAB1965 and 1190) markedly blocked infec-
tion by VSVDG*-ZaireGP and VSVDG*-RestonGP, while
others (e.g., MAB1981) did not (Fig. 3). VSVDG*-VSVG
infectivity was not appreciably reduced by any of the
antibodies. These data suggest that cell surface inte-
grins, especially those in the b1 group, are likely partic-
FIG. 2. Downregulation of integrins by expression of Ebola GPs. 293
were incubated with rabbit polyclonal antibodies to Zaire GP/SGP or inf
integrin mouse monoclonal antibodies (Chemicon), followed by incuba
respectively.ipants in Ebola virus entry into host cells. This hypothe-
sis was examined further by testing the inhibitory effects
b
iof purified integrins on the infectivity of the pseudotyped
VSVs. As shown in Fig. 4, of three commercially available
heterodimer integrins (a5b1, aVb3, and aVb5; Triton
-100 or octyl-b-D-glucopyranoside formulation, Chemi-
on), only a5b1 inhibited the infectivity of VSVDG*-
aireGP and VSVDG*-RestonGP; none altered VSVDG*-
SVG infectivity, although aVb3 did produce slight inhi-
transfected with each plasmid were subjected to FACS analysis. Cells
virus, A/turkey/Ontario/7732/66 (H5N9), and with respective antihuman
th secondary antibodies conjugated with phycoerythrin (PE) and FITC,T cells
luenzaition of the VSVDG*-ZaireGP and VSVDG*-RestonGP
nfection. These results, together with the antiviral activ-
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25RAPID COMMUNICATIONity of the anti-integrin antibodies, support a contribution
from the b1 integrins to cellular entry of Ebola viruses.
One putative receptor for the filoviruses is the asialo-
lycoprotein receptor found exclusively on hepatocytes
1). However, since filoviruses are pantropic and cell
ines lacking this receptor are susceptible to the virus
13, 14), other receptors must exist. Our previous study
howed that a cell surface glycoprotein with N-linked
ligosaccharide side chains plays an important role in
irus entry, presumably serving as a receptor or a cofac-
or (14). Taken together with our current data, we hypoth-
size that integrins are involved in Ebola virus entry.
The picture emerging from this study is that the inte-
rins, the b1 molecules especially, may intracellularly
nteract with GPs during their movement through the
ntracellular membrane traffic, resulting in downregula-
ion of these receptors and eventually cell rounding and
etachment. Since integrins also participate in cell–cell
nteractions involving lymphocytes, their reduced expres-
ion in cells infected with Ebola virus could affect the
fficiency of T-cell binding to the infected cells (3), which
ay hinder the induction of adequate immune responses
o the virus. Further elucidation of how the Ebola GP
ownregulates integrin molecules should provide impor-
ant additional insight into the mechanism of Ebola virus
ntry.
FIG. 3. Inhibition of pseudotyped VSV infection by anti-b1 integrin
antibodies. 293 cells were preincubated with anti-b1 integrin monoclo-
nal antibodies, MAB1965 (Chemicon), MAB1981 (Chemicon), and
MAB1190 (Serotec) (ascites, 1:50 dilution), for 2 h at 37°C, and then
infected with VSV pseudotyped with Zaire GP (VSVDG*-ZaireGP), Re-
ston GP (VSVDG*-RestonGP), or VSV G (VSVDG*-VSVG), as described
previously (14). Briefly, appropriately diluted viruses (105 infectious
nits/ml) were inoculated into cell monolayers, followed by a 1-h
ncubation. Infectivity was then determined by counting the cells ex-
ressing green fluorescent protein, which was encoded by the VSVDG
enome. The number of infected cells treated with normal rabbit or
ouse serum was set at 100. Each bar represents the mean percent-ge of infected cells 6 standard deviation in three independent exper-
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